For secondary outcomes Sativex was associated with a nominally significant improvement in hyperactivity/impulsivity (p=0.03) and a cognitive measure of inhibition (p=0.05), and a trend towards improvement for inattention (p=0.10) and EL (p=0.11).
Excerpts
Variance between severity groupings was slightly significant (homogeneity of variance, F (2, 45) = 3.48, P = 0.03) in bacterial data with a significant difference between confidently healthy and severe mange.
They did find that AKI was associated with mildly significant greater percent increases in urinary YKL-40 ( p = 0.03), NGAL ( p = 0.02), alpha-1 microglobulin ( p = 0.009), and IL-18 ( p = 0.03), but no adjustments were performed for baseline differences between those with and without AKI [ 22 ].
However, among the 116 EpiScores, only CXCL10 showed a nominally significant difference ( p = 0.03 95% CI: 0.001–0.0188; Figure 1 ), but this did not remain significant after FDR adjustment, highlighting the uncertainty of small effect sizes. 3.5.
When comparing changes in mating type ratios across the dominant vc types (EU‐01, EU‐02 and EU‐05, Figure 5a ), we detected a marginally significant increase in MAT ‐ 2 for vc type EU‐02 (Fisher's exact test; p = .03).
However, neurons that encoded absolute time were more prevalent in M2, and showed a similar trend in PPC, although this did not reach statistical significance (M2: p = 0.03, PPC: p = 0.06, permutation test; Fig. 2e ).
Nominally significant CNV*PRS interaction effects included schizophrenia (B = -0.1, p = 0.03), brain surface area (B = -0.05, p = 0.04), autism spectrum disorder (B = 0.03, p = 0.02).
There was a highly significant ( p = 0.030) between the two groups and it shown in Figure 1A , regarding SOD levels.
Using the multivariable time-dependent mixed model we found that, patients on antihypertensive and antihyperlipidemic monotherapy, those that reach the deductible limit are slightly (barely significant) more adherent than those that have not yet reached the deductible limit, with a relative adherence ratio (RAR) of 1.03 (95% CI: 1.00–1.05, p = 0.03) for antihyperlipidemic therapy and 1.02 (95% CI: 1.00–1.04, p = 0.05) for antihypertensive therapy.
A favorable trend in OS in the pembrolizumab group was also observed (HR 0.72, 95% CI 0.51-1.02; P=0.03) ( 42 ).
We observed a decreasing trend in the white race with P = 0.03.
In contrast, limited coordinated immune remodeling was observed between CB and NCB patients; only one population, CD3 + CD8 + PD-1 + PD-L1 + T cells, showed a nominally significant ( p = 0.030, q = 0.87, Wilcoxon rank-sum test) increase following treatment, preferentially in NCB patients ( Figure 5 B).
Among those with index dates in 1996–2010, differences between the GD subjects and the controls with a history of specialist‐level psychiatric treatment prior to index date appeared quite large but did not reach statistical significance (23.7% vs. 11.8%, p = 0.03).
showed a trendP =.03
Those taking short-acting opioids as needed (PRN) showed a trend toward reduced opioid dose across the daily assessments (β=–29.88, SE 10.68, P =.03), although this association did not survive correction.
borderline significanceP = .03
For the MR analysis of the opposite direction (IBD to CHIP), we observed a close to null effect (OR IVW , 0.98; 95% CI, 0.96-1.00) of CD to CHIP with borderline significance ( P = .03; supplemental Table 12 ), compared with the CHIP-to-IBD direction (OR IVW , 1.15; 95% CI, 1.03-1.27), suggesting a potential bidirectional relationship.
Only the difference between proximal jejunum and distal ileum showed a strong trend ( p = 0.03).
There was a significant trend towards less sepsis-related GI complications in the probiotic group too (9% vs. 36%, P = 0.03).
For WT mice only, the effect of treatment appeared to have a marginal trend toward a decrease in size (− 3.4%, p < 0.03, q < 0.16).
of borderline significanceP = 0.030
The correlation between TNF-α and ABC was of borderline significance ( P = 0.030, q = 0.050).
There is an almost significant but small dependence on the moving velocity (F(3,9) = 4.89, p = 0.03): the higher the moving speed, the bigger the deviation and, consequently, the stronger the illusion.
This may be an artefact of the reduced sample size in the isotopic analyses and a relatively weakly significant relationship between mandibular shape and δ 15 N values ( p = 0.03).
IENFD showed an overall trend toward being significantly lower in those with painful compared to painless DPN (SMD −0.31, 95% CI −0.59 to −0.02, p = 0.03, I 2 69%) (Figure 4 ).
However, there was a suggestive trend toward an increase in daily smartphone use (OR 4.10, 95% CI 1.15-14.6; P =.03) and the number of smartphone use purposes (mean difference 0.58, 95% CI 0.12-1.05; P =.01) among participants in the intervention arm.
Between 30STST and 6MWT a high (r=0.73 p<0.001) and between 30STST and 10SCT a moderately significant correlation was found (r=-0.39, p=0.03).
borderline significanceP = 0.03
M GMV also showed borderline significance for resting tremor ( P = 0.03) but not for postural-kinetic tremor.